| [1] AISSAOUI H,PREVOST C,BOUCHARABA A,et al. MDA-9/syntenin is essential for factor VIIa-induced signaling,migration,and metastasis in melanoma cells[J]. J Biol Chem,2015,290(6):3333-3348.[2] BEEKMAN J M,COFFER P J. The ins and outs of syntenin,a multifunctional intracellular adaptor protein[J]. J Cell Sci,2008,121(Sup 9):1349-1355.[3] BAIETTI M F,ZHANG Z,MORTIER E,et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes[J]. Nat Cell Biol,2012,14(7):677-685.[4] GHOSSOUB R,LEMBO F,RUBIO A,et al. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2[J]. Nat Commun,2014,5:3477.[5] HELMKE B M,POLYCHRONIDIS M,BENNER A,et al. Melanoma metastasis is associated with enhanced expression of the syntenin gene[J]. Oncol Rep,2004,12(2):221-228.[6] LIN J J,JIANG H,FISHER P B. Melanoma differentiation associated gene-9,mda-9,is a human gamma interferon responsive gene[J]. Gene,1998,207(2):105-110.[7] KEGELMAN T P,DAS S K,EMDAD L,et al. Targeting tumor invasion:the roles of MDA-9/Syntenin[J]. Expert Opin Ther Targets,2015,19(1):97-112.[8] YANG Y,HONG Q,SHI P,et al. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival[J]. Breast Cancer Res,2013,15(3):50.[9] BOUKERCHE H,SU Z Z,EMDAD L,et al. MDA-9/ Syntenin:a positive regulator of melanoma metastasis[J]. Cancer Res,2005,65(23):10901-10911.[10] LIU X,ZHANG X,LV Y,et al. Overexpression of syntenin enhances hepatoma cell proliferation and invasion:potential roles in human hepatoma[J]. Oncol Rep,2014,32(6):2810-2816.[11] KEGELMAN T P,DAS S K,HU B,et al. MDA-9/syntenin is a key regulator of glioma pathogenesis[J]. Neuro Oncol,2014,16(1):50-61.[12] KIM W Y,JANG J Y,JEON Y K,et al. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38,AKT,focal adhesion kinase and SP1[J]. Exp Mol Med,2014,46:e90.[13] D'ADDARIO G,FRUH M,RECK M,et al. Metastatic non-small-cell lung cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J]. Ann Oncol,2010,21 (Sup 5):v116-119.[14] HERBST R S,HEYMACH J V,LIPPMAN S M. Lung cancer[J]. N Engl J Med,2008,359(13):1367-1380.[15] HOFFMAN P C,MAUER A M,VOKES E E. Lung cancer[J]. Lancet,2000,355(9202):479-485.[16] MILLER Y E. Pathogenesis of lung cancer:100 year report[J]. Am J Respir Cell Mol Biol,2005,33(3):216-223.[17] MARCH T H,MARRON-TERADA P G,BELINSKY S A. Refinement of an orthotopic lung cancer model in the nude rat[J]. Vet Pathol,2001,38(5):483-490.[18] GANGEMI R,MIRISOLA V,BARISIONE G,et al. MDA-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression[J]. PLoS One,2012,7(1):e29989.[19] LIU H,YANG L,DING Y,et al. Prognostic value of syndecan binding protein in colorectal carcinoma[J]. Nan Fang Yi Ke Da Xue Xue Bao,2015,35(7):1003-1007.[20] CUI L,CHENG S,LIU X,et al. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis[J]. Oncotarget,2016,7(50):82634-82647.[21] LEE H,KIM Y,CHOI Y,et al. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1[J]. Biochem Biophys Res Commun,2011,409(1):148-153.[22] DAS S K,GUO C,PRADHAN A K,et al. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis[J]. Oncotarget,2016,7(30):46848-46861.[23] WANG L K,PAN S H,CHANG Y L,et al. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma[J]. Oncotarget,2016,7(1):386-401. |
